OTLK - OUTLOOK THERAPEUTICS INC. (NASDAQ: OTLK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outlook Therapeutics Inc. | Benzinga

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

• Do you, or did you, own shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK)?
  
  
• Did you purchase your shares between December 29, 2022 and August 29, 2023, inclusive?
  
  
• Did you lose money in your investment in Outlook Therapeutics, Inc.?
  
  
• Do you want to discuss your rights?

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Outlook Therapeutics, Inc. ("Outlook" or the "Company") (NASDAQ:OTLK) between December 29, 2022 and August 29, 2023, inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the District of New Jersey and alleges violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").

If you purchased or acquired Outlook securities, and/or would like to discuss your legal rights and options please visit Outlook Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or 

OTLK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outlook Therapeutics, Inc.>Full story available on Benzinga.com